News | March 24, 2025
AstraZeneca to invest $2.5 billion in new global strategic R&D centre in China
Investment includes biotech agreements with Harbour BioMed, Syneron Bio and BioKangtai
Investment includes biotech agreements with Harbour BioMed, Syneron Bio and BioKangtai
Dimethyl Fumarate Modified Release Capsules are indicated for the treatment of relapsing forms of multiple sclerosis
The new office in New Delhi marks a significant funding in the APAC region and reinforces the company’s commitment to advancing respiratory care in India
This facility represents a significant step in Croda’s Pharma business strategy to ‘Empower biologics delivery’
Experts urge early detection & better access to care
Amplitude Surgical is a European MedTech leader in high-quality, lower-limb orthopaedic technologies
403 entries from 22 states covering 168 districts highlight groundbreaking initiatives vital to improving national nutrition metrics.
MET-X, a novel metallo-beta-lactamase (MBL) inhibitor, has shown best-in-class performance in preclinical studies
This innovative platform is strategically essential to developing and scaling high-value life sciences use cases such as streamlining the content supply chain
Theatre (OTs) dedicated to cataract, LASIK, and retina treatments added to meet the growing demand
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
